ARKK Holdings of 10x Genomics (TXG) - Updated Daily
Single Cell GenomicsCell AnalyticsLab EquipmentLab EquipmentSpatial GenomicsWorkflow Automation
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 1.95% | $5.64b |
| 🏋🏿♂️Weight Rank In ARKK | 🌏Country |
| 19 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 21 | $153.19 |
| 🎫ARK Ownership Percent | |
| 2.96% | |
| Description | |
|---|---|
| 10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. | |
| Website | |
| www.10xgenomics.com |
Other ETFs That Hold TXG
Research Notes and Commentary for TXG
February 22, 2022
February 22, 2022: ARK Trades and Storylines
Trading Floor
November 4, 2021
TXG Close to Profitability, PACB Ramping
Trading Floor
August 20, 2021
August 18-20, 2021: ARK Trades and Storylines
Trading Floor
January 29, 2021
Ark Trades and Storylines
Trading Floor
10x is a workflow company that sells their system to the next-generation therapy companies like CRSP, FATE, CLLS and a host of other companies in...January 7, 2021
Daily Ark Digest
Trading Floor